Author

Matthew B. Robers

Promega (United States)ORCID 0000-0001-8505-5227Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Matthew B. Robers1 paper · Promega Corporation

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Assay:proteomics· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Research Focus:benchmarking· 1 Research Focus:cell-cell communication· 1 Organism:human· 1

Frequent Co-Authors

Alison Donnelly AxtmaniD· 2 shared Frances M. BashoreiD· 2 shared Amelie Menge· 1 shared Ani MichaudiD· 1 shared Cameron Damgaard· 1 shared David Harold DrewryiD· 1 shared Efrat Shaham Barda· 1 shared Francesco GrecoiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Alison Donnelly AxtmanORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cell BiologyJournal of Medicinal ChemistryPeer-reviewedFeb 6, 2026

Cellular Context Influences Kinase Inhibitor Selectivity

M. Binder, Frances M. Bashore, Kaitlin K. Dunn Hoffman…·Alison Donnelly Axtman

The paper compares cell-free and cellular assays for kinase inhibitor selectivity, finding divergent results and identifying new kinase interactions in cells.

10 citationstop 1%

proteomicsexperimental assay

𝕏 PostBluesky

BiochemistryACS Chemical BiologyPeer-reviewedJan 3, 2025

Functional characterization of pathway inhibitors for the ubiquitin-proteasome system (UPS) as tool compounds for CRBN and VHL-mediated targeted protein degradation

Martin P. Schwalm, Amelie Menge, Lewis Elson…·Stefan Knapp

The paper evaluates diverse ubiquitin pathway inhibitors as controls for CRBN and VHL-mediated protein degradation, assessing their potency and toxicity using the HiBiT system and high content assays.

15 citations

proteomicsexperimental assay

𝕏 PostBluesky

Cell BiologyFrontiers in Chemical BiologyPeer-reviewedJul 29, 2024

Development of SYK NanoBRET Cellular Target Engagement Assays for Gain-of-Function Variants

Jacob L. Capener, James D. Vasta, Vittorio L. Katis…·Frances M. Bashore

The paper develops a NanoBRET assay to study SYK gain-of-function variants in live cells and demonstrates inhibitor efficacy against these variants.

6 citations

humanproteomics

𝕏 PostBluesky